Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

852.22 +14.93 (+1.78%)
Streaming Delayed Price Updated: 12:37 PM EDT, Jun 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Eli Lilly

< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
81 82 Next >
7 Growth Stocks to Sell in March Before They Crash & Burn
Growth stocks are on fire to start 2024. But when the rally loses steam, these seven growth stocks to sell will come crashing down. 
Via InvestorPlace
Is WW Stock on the Brink of Bankruptcy?
It's hard to see what WW, the company formerly called Weight Watchers, can do now that Oprah Winfrey has turned against it. 
Via InvestorPlace
Should Investors Worry About Eli Lilly's Latest Regulatory Setback?
There are good reasons to remain optimistic. 
Via The Motley Fool
7 Delightful Dividend Stocks to Put Some Spring in Your Step
The best dividend stocks can be counted on to give a reliable return to income investors. These seven names are among the best to buy now. 
Via InvestorPlace
Top 7 Biotech Winners Of Novo Nordisk, Eli Lilly's Outsourcing Strategy For Weight-Loss Drugs: Goldman Sachs
Goldman Sachs analysts identified a substantial opportunity in the manufacturing sector for new obesity therapeutics, as demand for these treatments escalates. 
Via Benzinga
2 No-Brainer Stocks I'd Add to the "Magnificent Seven"
They fit right in. 
Via The Motley Fool
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
Via Benzinga
Behind the Scenes of Eli Lilly and Co's Latest Options Trends
Via Benzinga
Eli Lilly Taps Amazon's Pharmacy To Deliver Meds, Including Weight-Loss Drug Zepbound
The company is bolstering the ways it delivers medicines through its new LillyDirect website. 
Via Investor's Business Daily
Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
One of the primary features of Bill Gates biotech stocks is they are all working towards a cure for HIV and related illnesses. 
Via InvestorPlace
Why Is Gaxos.ai (GXAI) Stock Up 134% Today?
Gaxos.ai stock is up Wednesday with heavy trading of GXAI shares alongside it acquiring rights to new AI-enabled technology. 
Via InvestorPlace
Pharmaceutical Crime Jumps 50% As Criminals Seek To Capitalize Rising Tide of Counterfeit Weight-Loss Drugs
Combatting counterfeit weight-loss drugs: Insights into the surge, global impact, and efforts by pharmaceutical giants like Novo Nordisk and Eli Lilly to protect consumers. 
Via Benzinga
Why Is MicroCloud Hologram (HOLO) Stock Up 31% Today?
MicroCloud Hologram stock is up on Wednesday with heavy trading of HOLO shares ahead of a potential AI catalyst next week. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
Is Eli Lilly the Best Pharmaceutical Stock for You?
Lilly's recently approved weight-loss drug is off to a good start. 
Via The Motley Fool
LLY Stock Alert: You Can Now Get Eli Lilly’s Weight Loss Drugs on Amazon
Eli Lilly stock is on the move Wednesday morning as investors in LLY shares learn about a new pharmacy partnership with Amazon! 
Via InvestorPlace
Obesity Drugs On Amazon - Eli Lilly Partners With Amazon's Pharmacy Unit To Deliver Drug Prescriptions, Including Popular Zepbound For Weight Loss
Amazon Pharmacy integrates LillyDirect, offering home delivery of diabetes, obesity, and migraine medications. Enhance access with prompt doorstep delivery by trusted providers. Eli Lilly's partnership... 
Via Benzinga
Could Viking Therapeutics Challenge Giant Eli Lilly in the Billion-Dollar Weight-Loss Drug Market?
Viking aims to enter a market that may be worth $100 billion in a few years. 
Via The Motley Fool
Jim Cramer Says Tuesday Rally Was Driven By Nvidia, Eli Lilly And Other 'Stocks Reacting Positively To Good Earnings Per Share News'
CNBC's Jim Cramer has highlighted three stocks that are showing signs of recovery after facing consecutive losses. 
Via Benzinga
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
AnaptysBio exceeds Q4 2023 earnings expectations, with sales of $9.01 million. Expectations high post-Wedbush upgrade, foreseeing stock surge amid clinical milestones. Analysis compares PD-1 agonist... 
Via Benzinga
1 Big New Reason to Buy Novo Nordisk Stock Hand Over Fist Right This Instant
The pharma giant could have yet another knockout obesity drug on the way. 
Via The Motley Fool
Meet the Unknown Small-Cap Company That's Been Paying a Dividend for at Least 66 Years Longer Than Coca-Cola, ExxonMobil, and Eli Lilly
A relatively tiny company ($508 million market cap) that most investors have never heard of has been doling out a consecutive dividend for over two centuries -- including 104 years longer than... 
Via The Motley Fool
Gary Black Keeping Tabs On Oprah's Upcoming TV Special About Ozempic — 'Shame, Blame And The Weight Loss Revolution'
Future Fund co-founder Gary Black shared details about Oprah Winfrey's upcoming TV special discussing her weight loss journey and the use of GLP-1 weight loss drugs, potentially impacting stocks of... 
Via Benzinga
Forget Tesla: I Think This Stock Should Replace It in the "Magnificent Seven"
Tesla doesn't look very magnificent these days. But there's another stock that does. 
Via The Motley Fool
Meet the 5 Stocks That Have Contributed Almost All of the S&P 500's 2024 Gains
These companies have contributed the lion's share of the S&P 500's 7% year-to-date gain. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
Is Novo Nordisk a Buy After Its New Obesity Candidate's Success in a Clinical Trial?
Encouraging results recently pushed the pharma stock up to new heights. 
Via The Motley Fool
Missed Out on Eli Lilly and Novo Nordisk? This Could Be the Next Big Weight Loss Stock.
Viking Therapeutics has a promising anti-obesity treatment that is generating a lot of interest. 
Via The Motley Fool
The Top 3 Pharma Stocks to Buy in March2024
Investors explore the top three biotechnology stocks to buy in 2024 which are leading the anti-obesity market surge. 
Via InvestorPlace
The Best Stocks to Invest $50,000 in Right Now
These stalwart companies can help you grow your wealth. 
Via The Motley Fool
S&P 500 Soars To New Highs: 5 Best Stocks Ytd
Many semiconductor ETFs also touched new 52-week highs. 
Via Talk Markets
Topics ETFs Stocks
Exposures US Equities
Why Eli Lilly Stock Flopped on Friday
An important new drug's potential approval has been pushed back, and the timing is unclear. 
Via The Motley Fool
< Previous 1 2
...
9 10 11 12 13 14 15 16 17
...
81 82 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.